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Background: Somali women face exceptionally high mortality and incidence rates from both 
breast and cervical cancer. They experience an age-standardized breast cancer mortality rate of 
29.1 per 100,000 women, the highest in all of Africa, and an age-standardized breast cancer 
incidence rate of 41.7 per 100,000 women. Somalia’s second-highest cancer-related mortality 
and incidence rates are due to cervical cancer, both behind breast cancer. It is critical to identify 
the underlying factors that may influence healthcare workers’ management of both cancers. At 
present, there is no consensus regarding providers’ knowledge of different cancers and 
screening. 
Methods: A cross-sectional questionnaire was administered with a purposive sampling strategy 
to 469 healthcare professionals and students and was completed by 405 (86%). Healthcare 
workers were recruited from Mogadishu-based hospitals. 
Results: 197 healthcare professionals and 207 students completed the survey and were included 
in the analysis. 89% and 73% of respondents demonstrated good knowledge of breast and 
cervical cancer, respectively. Only 46% knew that a vaccine could prevent cervical cancer, and 
89% of healthcare professionals disagreed that HPV vaccines were available to their patients. 
Attitudes towards cancer screening, in addition to breast self-examination, were overwhelmingly 
positive. For both breast and cervical cancer, 24% reported having treated a patient and 30% 
reported having conducted a screen for either disease. 
Conclusion: Overall, while knowledge of both diseases and screening was good, there remain 
areas for clear educational targeting such as HPV vaccine availability and breast cancer 
preventability. Attitudes to screening for both diseases were exceedingly positive, but, with the 
exception of breast self-examination, failed to translate into practice due to inadequate resources 
and patient refusal. Future investments into Somalia’s chronic care management should prioritize 
technology necessary to conduct screenings for both diseases, expanding HPV vaccine access, 
and understanding patients’ potential motivations for refusing screening at the current moment. 
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Breast cancer (BC) is the most frequently diagnosed cancer among women globally, with an 
estimated 2.3 million new cases in 2020.1 In addition, BC is also the worldwide leader in female 
cancer deaths, claiming an estimated 685,000 lives in 2020.1 In contrast to many high-income 
countries where the incidence and mortality of BC have remained fairly consistent, these 
measures have rapidly increased in lower-income countries undergoing an epidemiological 
transition.2 3 Mortality has increased rapidly in Africa, which experiences an age-standardized BC 
mortality rate of 19.4 per 100,000 people, higher than any other continent.1 Due to several 
contributing factors including scarce cancer diagnostic facilities,4 persistently long wait times,5 and 
limited cancer education,5 6 many women present with late-stage disease, heightening their risk 
for mortality.  
 
Patients’ knowledge and attitudes toward BC are essential determinants of early detection, and it 
is well-established that the early diagnosis of BC is effective at reducing mortality rates.7 8 Yet, 
the evidence concerning stakeholders’ perceptions and knowledge of BC and screening programs 
in some low- and middle-income countries (LMICs) remains sparse. Furthermore, breast self-
examinations (BSE) have been known as a cost-effective intervention with the potential to assist 
in the early detection of BC,9 10 empower women to take a role in their health promotion,11 12 and 
may encourage future professional breast examinations,13 but attitudes toward BSEs remain 
unexplored in many LMICs. 
 
Globally, there were an estimated 570,000 new cervical cancer (CC) cases as well as an 
estimated 311,000 deaths attributed to the disease in 2018.14 CC has also been found to be the 
leading cause of cancer-related deaths in women in many African countries.14 Furthermore, the 
incidence of the disease has been found to be increasing in almost every sub-Saharan African 
country for which data are available.15 The region is known to have the greatest age-standardized 
incidence rate of CC in the world,15 as about 90% of the world’s CC cases occur in sub-Saharan 
Africa.15 
 
CC is a preventable disease; modeling studies demonstrate that, with widespread, high-coverage 
scale-up of Human Papillomavirus (HPV) vaccination and screening services, the elimination of 
this disease is possible.16 These screening programs can be radically effective in conjunction with 
the highly efficacious bivalent and quadrivalent HPV vaccines in addition to widespread Pap 
testing.14 15 
 
Somali women face exceptionally high mortality and incidence rates from both BC and CC. They 
experience an age-standardized BC mortality rate of 29.1 per 100,000 women, the highest in all 
of Africa,17 and an age-standardized BC incidence rate of 41.7 per 100,000 women.1 Somalia’s 
second-highest cancer-related mortality and incidence rates are due to CC, both behind BC.1 
Additionally, it is hypothesized that these numbers are underreported as qualitative studies of 
Somali refugees have demonstrated a preference of women to avoid CC screening due to a fear 
of the disease and a preference to die without knowing that they have cancer.18  
 
Somali women have some of the lowest health indicators in the world, with a life expectancy of 
59 years.19 They face many barriers in utilizing their country’s healthcare system, including a lack 
of consistent electricity at about half of surveyed healthcare facilities in Somalia.20 Persistent 
unaffordable prices and a lack of regulation have resulted in general distrust towards the nation’s 
healthcare system, leading to reports of poor care-seeking behavior among Somalis.21 Moreover, 
prolonged conflict by way of thirty years of civil war has severely damaged the country’s 
healthcare infrastructure, leaving its inhabitants vulnerable to climate-related disasters and a lack 
of consistent care for chronic conditions.22 23  
 
Currently, Somalia does not have an HPV vaccination program and its Ministry of Health reports 
that HPV vaccines are unavailable throughout the country.24 Additionally, informal conversations 
with hospital leaders in Mogadishu have revealed that mammography equipment are also widely 
unavailable, forcing physicians to turn to alternative breast cancer screening methods, such as 
clinical histories, biopsies, and ultrasounds.  
 
It is critical to explore the individual and institutional elements that may inhibit comprehensive 
cancer care in Somalia, especially as they pertain to healthcare workers’ practice of early 
detection of both cancers.  At present, assessments of providers’ knowledge of different cancers 
and screening in the Horn of Africa provide conflicting reports. A study of Ethiopian female 
healthcare workers demonstrated relatively high knowledge concerning CC,25 while another 
study among Eritrean nurses showed poor knowledge of BC risk factors.26 A final study among 
urban health extension workers in central Ethiopia found that over half of respondents had BSE 
knowledge that did not necessarily translate into clinical practice.27 However, healthcare 
workers ultimately have the potential to promote patient knowledge regarding cancer screening 
on a large scale.28 By supporting their ability to translate knowledge into practice, empowered 
healthcare workers can be effective patient educators.26  
 
To our knowledge, this study serves as the first investigating Somali healthcare professionals’ 
and students’ knowledge, attitudes, and practices (KAP) toward breast cancer, cervical cancer, 




Design and Instrument 
A descriptive, cross-sectional KAP study among healthcare professionals and students 
concerning BC, CC, and screening practices was carried out in Mogadishu, Somalia from 
February 15th, 2021 until March 28th, 2021. The 40-item survey tool consisted of 8 sections: 
demographic information, knowledge, attitudes, and practices regarding both cancers, and a 
separate section specific to BSE. Kress et al. examined the KAP concerning CC and screening 
among nurses, midwives, medical students, general practitioners, internists, pediatricians, and 
obstetricians/gynecologists in Ethiopian hospitals.29 Their survey were adapted to include 
questions pertaining to BC, BC screening, and BSE from two other studies examining healthcare 
providers’ KAP in the African continent.26 30 The English questionnaire was translated to and from 
Somali language by the data collectors and was available both in print and online format. In order 
to permit comparison to published investigations in neighboring countries, a threshold of ≥50% of 
questions answered correctly was adopted to signify a “good” knowledge level. 
 
In order to minimize experimenter bias, multilingual healthcare professionals from the Hagarla 
Institute, a Mogadishu-based non-profit organization dedicated to furthering clinical research, 
capacity-building, and skills transfer for medical personnel across Africa, underwent training as 
data collectors at SIMAD University’s Institute for Medical Research.  
 
Sample and Setting 
The survey was administered to 469 Mogadishu-based healthcare professionals and students 
and was completed by 405 participants with a 86% completion rate. To counter bias stemming 
from nonresponse, an a priori determination was made to remove data from participants who did 
not respond to at least 85% of questions.  
 
A purposive sampling method was utilized to survey healthcare professionals and students from 
healthcare-delivering institutions near Mogadishu, Somalia. Due to their direct involvement in 
Somali women’s potential cancer care, the survey aimed to receive responses from medical 
students, midwives, general ward nurses, head nurses, obstetrician/gynecologists, radiologists, 
and general surgeons. The purposive sampling strategy was employed to compensate for an 
inability to access employee registries at participating institutions from which to randomly sample 
and to ensure a sufficient amount of responses from a variety of patient-facing healthcare workers 
that provide BC or CC care to patients. Participants were mostly recruited from the following 
hospitals in Mogadishu: Dr. Sumait Hospital at SIMAD University, Banadir Hospital, Madina 
Hospital, Racep Tayyip Erdoğan Hospital, Keysaney Hospital, Dr. Hawa Abdi Hopsital, Somali 
University Hospital, Somali-Syrian Hospital, Shaafi Hospital, and Daynile Hospital. 
 
Data Analysis 
Responses were either collected directly in Qualtrics or were manually input onto the survey 
software in English. Data were exported for analysis on SAS Studio v.9.4.31 Descriptive statistics 
are reported using median and standard deviation calculations for continuous variables, along 
with frequency and percentages of responses for categorical variables. Bivariate and multivariate 
logistic regression analyses were utilized to examine how pre-existing attitudes and levels of 
knowledge may predict variables of interest, such as frequency of screening procedures 
completed. An alpha of 0.05 was utilized for all analyses. 
 
Ethical Considerations 
This study received approval from the ethics board at SIMAD University’s Institute for Medical 
Research and was deemed exempt from review by the Yale IRB (ID #2000029594). Verbal 
informed consent was obtained by the researchers by way of a brief presentation regarding the 
investigation’s purpose, procedures, and requirements for participation. Potential participants 
were made aware that participation was voluntary and could be withdrawn at any moment, that 
their responses would be anonymous and confidential, and that their participation would in no 
way impact their relationship with their employer. Data collectors received monetary 




The survey received 405 complete responses. Participants who did not respond to at least 85% 
of the questions were removed from the analysis. All non-demographic questions had an option 
of “I don’t know” or “prefer not to say” to minimize this. One survey response from a participant 
who did not identify themselves as either a healthcare professional or student was excluded. The 
final analysis was conducted with 404 responses. 
 
Of the included responses, 49% were self-identified healthcare professionals, and 51% were 
health professional students. Among healthcare professionals, the highest sampled professions 
were general ward nurses (25%) and midwives (19%). Many students (42%) did not associate 
with any of the provided options, likely due to participating in the study before differentiating into 
specialties. The mean age of participants was 29.9 (SD ± 8.37), and 59% of respondents were 
female. Of practicing healthcare professionals, over 60% had been practicing for less than five 
years (Table 1). The most common affiliation among participants was with Banadir Hospital in 
Mogadishu. 
 
Eighty-nine percent of included participants had a good knowledge of BC, correctly answering at 
least 9/18 questions pertaining to BC risk factors, severity, and burden, while 61% showed 
superior knowledge by answering at least 12/18 questions correctly. Five questions were 
answered correctly by less than 50% of the sample. Two were regarding risk factors: First birth 
occurring after mother is ≥30 years old (49%); Use of oral contraceptive pills (46%), while the 
others related to those-at-risk and preventability of the disease: Breast cancer is preventable 
(8%); Breast cancer is most common among women in their 20s (45%); Only women can get 
breast cancer (46%) (Table 2). Healthcare professionals and students differed in their knowledge 
of risk factors; professionals were significantly more likely to recognize five (non-)risk factors: 
History of smoking (92% vs 82%); Family history of breast cancer (97% vs 89%); No history of 
breastfeeding (82% vs 73%); Having multiple sex partners (non-risk factor; 80% vs 65%); Larger 
breasts (non-risk factor; 65% vs 49%). Students correctly identified two risk factors at a 
significantly higher rate than healthcare professionals: First birth occurring after mother is ≥30 
years old (36% vs 63%); Use of oral contraceptive pills (30% vs 63%). 
 
Respondents had relatively less knowledge of CC. Seventy-three percent of respondents 
correctly answered at least 10/19 questions pertaining to CC, and 56% correctly responded to at 
least 12/19 questions. In addition to this poor overall performance, responses to CC questions 
exhibited more heterogeneity; more questions had significantly different response patterns across 
professional and student groups when compared to BC (Table 2). Healthcare professionals were 
statistically more likely to answer CC risk factor questions correctly across the board but were 
statistically less likely to answer the following questions about CC screening and presentation: 
Cervical cancer can usually be found at an early stage because of the obvious symptoms (False; 
23% vs 33%); Cervical cancer is most common among women in their 20s (False; 43% vs 62%). 
Of note, slightly above 50% of respondents correctly identified that there is a licensed vaccine 
that can prevent CC; healthcare professionals were statistically more likely to identify the 
existence of such a vaccine (65% vs 42%). Additionally, only 26% and 43% of respondents 
correctly identified that poor personal hygiene and use of intrauterine devices were not risk factors 
for CC, respectively. 
 
Attitudes towards screening were overwhelmingly positive for both cancers. Over 98% of 
respondents agreed that both BC and CC are serious diseases, that screening for both diseases 
is an essential part of women’s healthcare, and that a screening program for both cancers should 
be initiated in their community (Table 3). Relative to patients’ other needs, however, respondents 
were not as concerned about BC and CC screening, with over 92% stating that their patients have 
more pressing concerns than cancer screenings. Respondents also reported that a lack of 
resources inhibited screening, with over 96% reporting that they lacked two or more fiscal or 
technological resources required for screening. Among other barriers to screening reported, 30% 
of respondents reported patients refusing opportunities for BC or CC screens. 
 
Most respondents reported not having cared for breast and CC and precancerous patients. About 
24% reported having treated either BC or CC patients (Table 4), while 30% reported having ever 
conducted a BC or CC screening examination (Figure 1). Moreover, over 95% of respondents 
had a positive attitude towards the efficacy of BSEs (Table 5). Additionally, 92% were confident 
that they could detect abnormalities in breasts, and about 79% recommend that their patients 





To our knowledge, this is the first study to investigate Somali healthcare professionals’ and 
students’ knowledge, attitudes, or practices towards BC, CC, and screening for both diseases. 
The study utilized a purposive sampling technique to avoid neglecting any type of healthcare 
worker providing cancer care to Somali women, particularly midwives who play an invaluable role 
in providing reproductive health services across the nation.32 A large majority (89%) of 
respondents demonstrated a good knowledge of BC prevention and screening, risk factors, 
severity, and burden. This study provides evidence of Somali healthcare workers’ higher levels of 
BC knowledge compared to participants in nearby Northwest Ethiopia,33 Addis Ababa in Central 
Ethiopia,27 34 and Eritrea.26 As expected, healthcare professionals performed better than students 
at identifying BC risk factors. Surprisingly, a majority of healthcare professionals said that BC was 
most common in women in their 20s, potentially a reflection of growing trends of early onset BC 
plaguing sub-Saharan African populations.35 Also of note, overwhelming majorities of both 
professionals (94%) and students (89%) stated that BC was a preventable disease. 
 
With regards to CC, a majority (73%) of healthcare professionals and students demonstrated 
good knowledge. While lower than the BC scores, the current finding is higher than that of other 
sub-Saharan investigations in Tanzania and Côte d'Ivoire,36 37 and lower than that of Ethiopia and 
Nigeria.25 38 39 While only 54% of professionals and students knew that there was a vaccine 
available that could prevent CC, this is a higher rate than that identified in southern Ethiopia 
(36%).25  
 
Furthermore, there is reason to believe that healthcare professionals from other provinces of 
Somalia would demonstrate a worse knowledge of both cancers and screening practices. While 
Mogadishu-based medical universities’ curricula inform students about CC, BC, screenings, and 
HPV, the unavailability of screening equipment make it difficult to reinforce these concepts with 
practice. This effect may be heightened in more rural areas and smaller cities within Somalia 
where screening equipment is even less prevalent. In addition, the Somali Medical Association 
encourages attendance of biannual Continuing Medical Education events to reinforce established 
and introduce new concepts to graduated medical professionals.40 These events are only hosted 
in Somalia’s largest cities.  
 
Attitudes towards screening of both diseases proved remarkably positive. While 99% and 98% of 
respondents stated that screening for BC and CC was an essential part of women’s healthcare, 
respectively, a lack of access to services necessary for prevention and early detection of both 
diseases was reported. Furthermore, over 97% of respondents reported a lack of access to 
services essential for proper screening of either cancer, including laboratory equipment, money 
dedicated for screening tests, and follow-up capacity. Moreover, attitudes towards BSE were also 
exceedingly positive. Without a comprehensive BC screening program in place, widespread BSE 
may serve as an acceptable alternative for Somali women to become familiar with any changes 
in their breast, despite the method’s limitations. 
 
The vast majority (89%) of healthcare professionals disagreed with HPV vaccines being 
accessible for their patients, reinforcing the vaccine’s widespread unavailability in the nation.24 
Data concerning HPV’s prevalence in at-risk populations or confirmed cervical cancer cases 
remain unavailable.24 Before being able to guide primary or secondary cervical cancer prevention 
strategies, a comprehensive dedication to national HPV surveillance is required. In order to 
combat the second-leading cause of national cancer-related mortality,1 it is imperative that 
international organizations such as GAVI, for which Somalia is eligible,41 deliver aid to the sub-
Saharan African country in the form of HPV vaccinations.     
 
While Somali healthcare professionals and students demonstrated a robust approval of 
screening, they did not practice in a concordant manner, with almost 70% of respondents having 
never conducted a screening for either disease. A healthcare professional’s supervisory presence 
is required for Somali healthcare students to conduct screenings or offer recommendations. 
Students exclusively assist professionals as part of a cancer patient’s treatment team. While the 
availability of resources, both technological and human, reportedly played a substantial role in 
precluding healthcare workers from conducting screening, 30% of respondents reported a patient 
having refused screening for either cancer. These respondents reported in vast agreement that 
their patients refused screening for either cancer because it was looked down upon by friends or 
family, because they believed it would give them cancer, because they found it embarrassing, 
intrusive, or painful, among other reasons. An exception to this lack of screening practice was 
that of BSE, where 79% and 82% of respondents respectively reported frequently recommending 
that patients conduct BSEs and expressed confidence in their ability to teach the method. While 
cancer implementation science remains essential to discover the most effective way by which to 
launch screening programs for both diseases, we expect that other logistical and fiscal challenges 
related to scale-up would supersede that of Somali healthcare worker pushback and 
noncompliance.  
 
Further investigations will need to evaluate BC and CC screening in the Somali context. A 
monetary and technological investment is necessary to improve Somali healthcare workers’ ability 
to offer BC and CC screenings – a needs assessment evaluating the current infrastructure status 
and deficits is vital to understanding where to direct new commitments from governmental and 
international institutions. In addition, it will be impossible to improve uptake and minimize refusals 
without launching qualitative studies meant to understand the cultural nature of the stigma that 
surrounds and inhibits screening for both cancers. Finally, future investigations will need to assess 
Somali women’s knowledge and attitudes of cancer screenings in order to target future 
educational initiatives to potential deficits. This study aimed to fulfill a similar gap; educational 
initiatives will need to be targeted to increase healthcare workers’ understanding of BC 




This study is the first of its kind to examine the knowledge, attitudes, and practices of Somali 
healthcare workers as it relates to breast cancer, cervical cancer, and screening. While 
knowledge of both diseases and screening was generally good, there remain areas for clear 
educational targeting, such as the preventability of breast cancer and the existence of a vaccine 
that can prevent cervical cancer. Attitudes to screening for both diseases were all exceedingly 
positive, but failed to translate into practice due to inadequate resources and patient refusal. 
Attitudes toward breast self-examination were also remarkably positive and did translate to clinical 
recommendations. Future investments into Somalia’s chronic care management should prioritize 
technology necessary to conduct screenings for both diseases, expanding access to HPV 




As the conducted investigation was cross-sectional and survey-based in nature, recall and social 
desirability biases are among the study’s potential limitations. Furthermore, a second wave of 
COVID-19 cases has plagued Somalia and the Mogadishu area in February and March of 2021, 
when the study was in the data collection stage; the added time and emotional strain may have 
influenced the selection of participants. We attempted to mitigate this by eliminating individuals 
who completed less than 85% of the survey, who may have been stressed for time and skipped 
past questions. Lastly, as the study utilized a purposive sample of Mogadishu-based healthcare 
professionals and students, it is not intended to be a representative sample of Somali healthcare 
workers. Its generalizability is therefore limited. 
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Age (years)    
     ≤25 27 (13.7) 118 (58.7) 145 (36.4) 
     26-35 106 (53.8) 67 (33.3) 173 (43.5) 
     36-45 50 (25.4) 11 (5.5) 61 (15.3) 
     ≥46 14 (7.1) 5 (2.5) 19 (4.8) 
Sex    
     Male 85 (43.2) 81 (39.3) 166 (41.2) 
     Female 112 (56.8) 125 (60.7) 237 (58.8) 
Profession    
     Midwife 37 (18.8) 17 (8.2) 54 (13.4) 
     General Ward Nurse 50 (25.4) 45 (21.8) 95 (23.6) 
     Head Nurse 23 (11.7) 12 (5.8) 35 (8.7) 
     General Surgeon 17 (8.6) 20 (9.7) 37 (9.2) 
     Radiologist 26 (13.2) 5 (2.4) 31 (7.7) 
     Obstetrician/Gynecologist 23 (11.7) 21 (10.2) 44 (10.9) 
     Other 21 (10.7) 86 (41.8) 107 (26.6) 
Licensed (Certificate)†    
     Yes 98 (50.0) - 98 (50.0) 
     No 98 (50.0) - 98 (50.0) 
Years of Practice†    
     <1 25 (12.8) - 25 (12.8) 
     1-5 94 (48.2) - 94 (48.2) 
     6-10 52 (26.7) - 52 (26.7) 
     ≥11 24 (12.3) - 24 (12.3) 
* Values are frequency (column percent). Values may not add to 100 due to rounding 














Table 2 Knowledge concerning breast and cervical cancer risk factors, etiology, and prevention 
Question Healthcare Professionals  
Healthcare 
Students  Total P-value
† 
 Correct Answer*   
BREAST CANCER 
History of smoking (Risk Factor) 176 (91.7) 154 (81.5) 330 (86.6) 0.0035 
Family history of breast cancer 
(Risk Factor) 191 (97.4) 172 (89.1) 363 (93.3) 0.0010 
No history of breastfeeding (Risk 
Factor) 58 (81.9) 136 (73.1) 294 (77.6) 0.0413 
Having multiple sex partners 
(Non-Risk Factor) 144 (80.4) 112 (64.7) 256 (72.7) 0.0009 
First birth occurring after mother 
is ≥30 years old (Risk Factor) 65 (36.1) 108 (63.2) 173 (49.3) <0.0001 
Obesity (Risk Factor) 137 (74.9) 122 (69.7) 259 (72.4) n.s. 
Increased age (Risk Factor) 134 (70.9) 125 (70.2) 259 (70.6) n.s. 
Use of oral contraceptive pills 
(Risk Factor) 56 (30.3) 108 (63.2) 164 (46.1) <0.0001 
Larger breasts (Non-Risk Factor) 120 (64.9) 86 (48.6) 206 (56.9) 0.0018 
Breast cancer is one of the 
leading causes of death in women 
worldwide (True) 
187 (95.4) 173 (86.5) 360 (90.9) 0.0020 
Breast Cancer is preventable 
(False) 12 (6.2) 20 (10.9) 32 (8.5) n.s. 
It is possible to detect pre-
cancerous breast tissue cells 
(True) 
186 (95.4) 177 (92.1) 363 (93.8) n.s. 
The purpose of screening for 
breast cancer is to detect pre-
cancerous changes and the 
appearance of cancer (True) 
180 (92.8) 174 (90.6) 354 (91.7) n.s. 
If untreated, breast cancer can be 
fatal (True) 181 (93.8) 180 (93.3) 361 (93.5) n.s. 
Breast cancer is not curable 
(False) 143 (75.3) 130 (67.7) 273 (71.5) n.s. 
Breast cancer is most common 
among women in their 20s (False) 70 (37.8) 93 (52.8) 163 (45.2) 0.0042 
Only women can get breast 
cancer (False) 94 (49.0) 81 (43.6) 175 (46.3) n.s. 
Any woman is at risk for breast 
cancer (True) 139 (72.4) 143 (77.7) 282 (75.0) n.s. 
CERVICAL CANCER 
Smoking cigarettes (Risk Factor) 175 (92.6) 128 (67.0) 303 (79.7) <0.0001 
Poor personal hygiene (Non-Risk 
Factor) 48 (25.8) 50 (27.0) 98 (26.4) n.s. 
Having multiple sex partners 
(Risk Factor) 163 (86.7) 144 (80.0) 307 (83.4) n.s. 
Use of herbal remedies (Non-Risk 
Factor) 111 (62.0) 74 (46.0) 185 (54.4) 0.0030 
Use of tampons (Non-Risk 
Factor) 141 (77.0) 107 (62.9) 248 (70.2) 0.0038 
Infection with HPV (Risk Factor) 157 (82.2) 129 (77.2) 286 (79.9) n.s. 
Infection with HIV (Risk Factor) 142 (77.6) 105 (58.3) 247 (68.0) <0.0001 
Use of IUDs (Non-Risk Factor) 87 (48.3) 63 (37.3) 150 (43.0) 0.0371 
Cervical cancer is one of the 
leading causes of death in women 
worldwide (True) 
161 (82.6) 140 (71.8) 301 (77.2) 0.0113 
Cervical cancer is preventable 
(True) 157 (83.1) 150 (83.8) 307 (83.4) n.s. 
It is possible to detect pre-
cancerous cervical cells (True) 188 (96.4) 177 (94.2) 365 (95.3) n.s. 
The purpose of screening for 
cervical cancer is to detect pre-
cancerous changes and the 
appearance of cancer (True) 
183 (94.8) 178 (94.7) 361 (94.8) n.s. 
If untreated, cervical cancer can 
be fatal (True) 180 (93.3) 172 (90.5) 352 (91.9) n.s. 
Cervical cancer is caused by a 
virus that is spread sexually 
(True) 
136 (76.8) 100 (58.8) 236 (68.0) 0.0003 
There is a vaccine that can 
prevent cervical cancer (True) 114 (65.1) 61 (41.5) 175 (54.4) <0.0001 
Cervical cancer is not curable 
(False) 136 (70.1) 117 (65.7) 253 (68.0) n.s. 
Cervical cancer is most common 
among women in their 20s (False) 81 (43.6) 112 (62.2) 193 (52.7) 0.0003 
For cervical cancer, the 
progression of pre-cancerous 
cells to cancer can take 10-20 
years (True) 
73 (42.9) 75 (46.8) 148 (47.6) n.s. 
Cervical cancer can usually be 
found at an early stage because 
of the obvious symptoms (False) 
45 (23.4) 60 (33.0) 105 (28.1) 0.0404 
* Values are frequency (percent). “I don’t know” responses were coded as missing. 
† P-value is for χ2 test between Healthcare Professionals and Healthcare Students.  
Sources: 26 29 30 42-44 
 
Table 3 Attitudes concerning breast cancer, cervical cancer, and barriers to screening 




 Strongly/Somewhat Agree*   
BREAST CANCER 
Breast cancer screening is an 
essential part of women’s 
healthcare 
193 (99.0) 201 (99.0) 394 (99.0) n.s. 
Breast cancer is a very serious 
disease 193 (99.0) 196 (99.5) 389 (99.2) n.s. 
A breast cancer screening 
program should be started or 
expanded in my community 
193 (99.0) 190 (97.9) 383 (98.5) n.s. 
My patients have more pressing 
health problems than screening 187 (96.9) 166 (87.8) 353 (92.4) 0.0008 
I have not had the necessary 
training in order to screen 138 (71.1) 156 (82.5) 294 (76.8) 0.0082 
The screening tests are too 
expensive for my patients 126 (65.0) 148 (81.3) 274 (72.9) 0.0004 
I do not have time or am too 
busy to screen 89 (45.9) 95 (51.4) 184 (48.6) n.s. 
I do not have the necessary 
equipment or supplies to screen 168 (86.2) 153 (79.3) 321 (82.7) n.s. 
The screening procedures are 
too difficult 96 (49.2) 100 (57.1) 196 (53.0) n.s. 
I do not have the necessary 
laboratory resources to screen 177 (92.2) 156 (84.3) 333 (88.3) 0.0174 
I do not have the capacity to 
follow-up with patients after 
screening 
116 (61.0) 135 (73.8) 251 (67.3) 0.0089 
CERVICAL CANCER 
Cervical cancer screening is an 
essential part of women’s 
healthcare 
190 (100.0) 190 (96.0) 380 (97.9) 0.0051 
Cervical cancer is a very serious 
disease 191 (100.0) 188 (97.4) 379 (98.7) 0.0252 
A cervical cancer screening 
program should be started or 
expanded in my community 
188 (99.5) 186 (97.4) 374 (98.4) n.s. 
My patients have more pressing 
health problems than screening 189 (97.4) 165 (88.2) 354 (92.9) 0.0005 
I have not had the necessary 
training in order to screen 136 (69.7) 158 (81.4) 294 (75.6) 0.0072 
The screening tests are too 
expensive for my patients 115 (59.9) 143 (77.3) 258 (68.4) 0.0003 
I do not have time or am too 
busy to screen 78 (41.5) 86 (46.5) 164 (44.0) n.s. 
I do not have the necessary 
equipment or supplies to screen 172 (87.8) 158 (84.0) 330 (85.9) n.s. 
The screening procedures are 
too difficult 84 (43.8) 108 (61.4) 192 (52.2) 0.0007 
I do not have the necessary 
laboratory resources to screen 174 (90.2) 148 (80.4) 322 (85.4) 0.0075 
I do not have the capacity to 
follow-up with patients after 
screening 
103 (54.8) 126 (67.7) 229 (61.2) 0.0101 
* Values are frequency (percent). “I don’t know” responses coded as missing. 






























Table 4 Practices concerning breast and cervical cancer diagnosis and treatment‡ 




 Yes*  
BREAST CANCER 
Have you ever diagnosed a 
patient with pre-cancerous 
breast lesions? 
13 (11.2) 20 (12.7) 33 (12.0) n.s. 
Have you ever treated a 
patient with pre-cancerous 
breast lesions? 
9 (7.8) 14 (9.2) 23 (8.6) n.s. 
Have you ever diagnosed a 
patient with breast cancer? 16 (13.8) 21 (13.7) 37 (13.8) n.s. 
Have you ever treated a 
patient with breast cancer? 17 (14.5) 16 (10.8) 33 (12.4) n.s. 
CERVICAL CANCER 
Have you ever diagnosed a 
patient with pre-cancerous 
cervical lesions? 
29 (14.7) 37 (18.3) 66 (16.5) n.s. 
Have you ever treated a 
patient with pre-cancerous 
cervical lesions? 
29 (14.7) 32 (16.2) 61 (15.5) n.s. 
Have you ever diagnosed a 
patient with cervical cancer? 43 (21.9) 33 (16.8) 76 (19.4) n.s. 
Have you ever treated a 
patient with cervical cancer? 42 (21.5) 28 (14.5) 70 (18.0) n.s. 
* Values are frequency (percent). “I don’t know” responses were coded as missing.  
† P-value is for χ2 test between Healthcare Professionals and Healthcare Students.  
‡ A healthcare professional’s supervisory presence is required for Somali healthcare students to 
conduct screenings or offer recommendations. Students exclusively assist professionals as part 












Figure 1 Proportion of medical doctors, nurses, and midwives having performed breast cancer 
screening procedures and cervical cancer screening procedures* 
 
* Cervical cancer screening procedures included pap smear, HPV DNA testing, liquid-based 
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Table 5 Attitudes and Practices towards Breast Self-Examination‡ 




 Strongly/Somewhat Agree*  
Have you heard of breast 
self-examinations? (Yes§) 164 (85.0) 152 (78.8) 316 (81.9) n.s. 
Breast self-examination is a 
useful tool for the early 
detection of breast cancer 
183 (97.3) 183 (94.3) 366 (95.8) n.s. 
Breast self-examination is 
difficult and time consuming 43 (24.4) 70 (38.0) 113 (31.4) 0.0054 
I am confident that I could 
detect abnormalities in a 
breast if there were any 
178 (97.3) 158 (87.3) 336 (92.3) 0.0004 
I am confident I could teach 
someone to conduct their 
own breast self-examination 
150 (81.1) 160 (83.3) 310 (82.2) n.s. 
I frequently recommend that 
patient conduct their own 
breast self-examination 
142 (82.6) 139 (75.1) 281 (78.7) n.s. 
* Values are frequency (percent). “I don’t know” responses were coded as missing. 
† P-value is for χ2 test between Healthcare Professionals and Healthcare Students. 
‡ A healthcare professional’s supervisory presence is required for Somali healthcare students to 
conduct screenings, provide treatment, or offer recommendations.   
§ Answers shown in table for Question 1 correspond to the response: “Yes” 
